Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
"9.83% average weight loss" (appears on some brand pages as 9.8%) - per Shed's published footnotes, this figure is from VIP member data based on self-reported weight entries
Aons analysis does not reflect: The most recent direct-to-consumer pricing options Newer strategies such as alternative payment methods, updated pricing agreements or emerging value-based approaches
February 2025 Hims & Hers oral semaglutide controversy: Strive manufactured the oral compounded semaglutide pill that Hims & Hers launched on February 5, 2025, using what Strive described as liposomal technology. Hims pulled the product two days after launch after coming under federal scrutiny
Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
